MONITORING UTILIZATION TRENDS OF GLUCOSE-LOWERING DRUGS FOR TYPE 2 DIABETES IN OLDER ADULTS BY FRAILTY STATUS

被引：0
|
作者：
Gopalakrishnan, Chandrasekar [1 ,2 ]
Kim, Dae [3 ]
Kutz, Alexander [4 ]
Patorno, Elisabetta [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Hebrew SeniorLife, Boston, MA USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
来源：
INNOVATION IN AGING | 2021年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：208 / 208
页数：1
相关论文
共 50 条
  • [21] Trends in utilization patterns of newer glucose-lowering drugs in US adults with type 2 diabetes and a history of coronary heart disease or heart failure: 2005-2019
    Alshehri, Alaa
    Guan, Dawei
    Li, Piaopiao
    Zhang, Yichen
    Ghayee, Hans K.
    Jiao, Tianze
    Shao, Hui
    PRIMARY CARE DIABETES, 2024, 18 (05) : 561 - 563
  • [22] Glucose-lowering effects of sulfasalazine in type 2 diabetes
    Haas, RM
    Li, P
    Chu, JW
    DIABETES CARE, 2005, 28 (09) : 2238 - 2239
  • [23] Cardiovascular Effects of Glucose-lowering Therapies for Type 2 Diabetes: New Drugs in Perspective
    Thompson, Peter L.
    Davis, Timothy M. E.
    CLINICAL THERAPEUTICS, 2017, 39 (05) : 1012 - 1025
  • [24] Changing Trends in Glucose-Lowering Drug Initiation for Type 2 Diabetes in the Era of Tirzepatide
    Patorno, Elisabetta
    Tesfaye, Helen
    Ortega-Montiel, Janinne
    Alix, Caroline
    Dicesare, Elyse C.
    Cromer, Sara Jane
    Wexler, Deborah J.
    Paik, Julie M.
    DIABETES, 2024, 73
  • [25] Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an update
    Tomlinson, Brian
    Chan, Paul
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (04) : 175 - 179
  • [26] Exploring the impact of type 2 diabetes and glucose-lowering drugs on gut microbiome dynamics
    Hafiz Muhammad Adnan Tariq
    Nayyab Younas Khan
    Haseeb Manzoor
    Masood Ur Rehman Kayani
    Discover Medicine, 2 (1):
  • [27] Deprescribing Glucose-Lowering Therapy in Older Adults with Diabetes: A Systematic Review of Recommendations
    Christiaens, Antoine
    Henrard, Severine
    Sinclair, Alan J.
    Tubach, Florence
    Bonnet-Zamponi, Dominique
    Zerah, Lorene
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2023, 24 (03) : 400 - 402
  • [28] Glycemic Control, Glucose-Lowering Medication Use, and Utilization among Older Patients with Diabetes
    Kuntz, Jennifer L.
    Nichols, Gregory A.
    DIABETES, 2017, 66 : A79 - A80
  • [29] Personalized glucose-lowering effect of chiglitazar in type 2 diabetes
    Huang, Qi
    Zou, Xiantong
    Chen, Yingli
    Gao, Leili
    Cai, Xiaoling
    Zhou, Lingli
    Gao, Fei
    Zhou, Jian
    Jia, Weiping
    Ji, Linong
    ISCIENCE, 2023, 26 (11)
  • [30] Canada Welcomes a Novel Class of Oral Glucose-Lowering Drugs People with Type 2 Diabetes
    Lau, David C. W.
    CANADIAN JOURNAL OF DIABETES, 2014, 38 (04) : 219 - 220
12345